Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Common Equity (2010 - 2026)

Exelixis (EXEL) posted quarterly Common Equity of $1.9 billion for Q2 2026, down 9.16% year-over-year from $2.1 billion in Q2 2025, and down 10.44% quarter-over-quarter from $2.2 billion in Q1 2026.

Analysis

Exelixis (EXEL) Common Equity (2010 - 2026) Analysis & Trends

Exelixis' Common Equity history runs 17 years deep, the most recent figure standing at $1.9 billion for Q2 2026.

  • In Q2 2026, Common Equity fell 9.16% year-over-year to $1.9 billion; the TTM figure through Apr 2026 stood at $1.9 billion (down 9.16% YoY), while the FY2026 annual figure was $2.2 billion, down 3.69% from the prior year.
  • Common Equity for Q2 2026 stood at $1.9 billion, down from $2.2 billion in the prior quarter.
  • The five-year high for Common Equity was $2.6 billion in Q1 2023, with the low at $1.9 billion in Q2 2026.
  • The 5-year median for Common Equity is $2.3 billion (2023), against an average of $2.3 billion.
  • The sharpest annual moves came in 2022 and 2024: Common Equity gained 20.02% in 2022, then decreased 16.72% in 2024.
  • Exelixis' Common Equity stood at $2.5 billion in 2022, then decreased by 9.02% to $2.3 billion in 2023, then gained by 0.51% to $2.3 billion in 2024, then slipped by 5.04% to $2.2 billion in 2025, then slipped by 10.41% to $1.9 billion in 2026.
  • Business Quant data shows EXEL's Common Equity at $1.9 billion in Q2 2026, $2.2 billion in Q1 2026, and $2.2 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 20.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 31.71 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.42 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 6.76 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.61 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.17 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.35 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.79 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 757.49 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 1.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 1.84 Bn
Apr 3, 2026 1.94 Bn
Jan 2, 2026 2.16 Bn
Oct 3, 2025 2.16 Bn
Jul 4, 2025 2.03 Bn
Apr 4, 2025 2.13 Bn
Jan 3, 2025 2.24 Bn
Sep 27, 2024 2.28 Bn
Jun 28, 2024 2.12 Bn
Mar 29, 2024 2.13 Bn
Dec 29, 2023 2.26 Bn
Sep 29, 2023 2.35 Bn
Jun 30, 2023 2.53 Bn
Mar 31, 2023 2.56 Bn
Dec 30, 2022 2.49 Bn
Sep 30, 2022 2.49 Bn
Jul 1, 2022 2.39 Bn
Apr 1, 2022 2.29 Bn
Dec 31, 2021 2.21 Bn
Oct 1, 2021 2.11 Bn